Mark J. Ratain to Trastuzumab
This is a "connection" page, showing publications Mark J. Ratain has written about Trastuzumab.
Connection Strength
0.105
-
Alternative Trastuzumab Dosing Schedules Are Associated With Reductions in Health Care Greenhouse Gas Emissions. JCO Oncol Pract. 2023 09; 19(9):799-807.
Score: 0.054
-
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clin Cancer Res. 2002 Dec; 8(12):3718-27.
Score: 0.051